We are live on ! Find out more
MGWM

Marks Group Wealth Management Portfolio holdings

AUM $1.04B
1-Year Est. Return 8.96%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+8.96%
3 Year Est. Return
+52.46%
5 Year Est. Return
+69.47%
10 Year Est. Return
AUM
$1.08B
AUM Growth
+$1.14M
Cap. Flow
-$24.7M
Cap. Flow %
-2.3%
Top 10 Hldgs %
18.23%
Holding
307
New
14
Increased
85
Reduced
125
Closed
13

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$8.51M
2
PLTR icon
Palantir
PLTR
+$6.19M
3
NVDA icon
NVIDIA
NVDA
+$6M
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$4.37M
5
JBL icon
Jabil
JBL
+$2.93M

Sector Composition

Rank Sector Weight
1 Industrials 23.21%
2 Technology 19.89%
3 Financials 15.38%
4 Healthcare 11.84%
5 Consumer Discretionary 8.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ENB icon
101
Enbridge
ENB
$123B
$2.9M 0.27%
57,425
-766
-1% -$36K
WDEF
102
WisdomTree Europe Defense Fund
WDEF
$89.7M
$2.85M 0.26%
+84,526
New +$2.54M
WFC icon
103
Wells Fargo
WFC
$263B
$2.84M 0.26%
33,926
+508
+2% +$41.2K
MDT icon
104
Medtronic
MDT
$107B
$2.81M 0.26%
29,497
+671
+2% +$61.7K
QUAL icon
105
iShares MSCI USA Quality Factor ETF
QUAL
$46B
$2.81M 0.26%
14,443
-129
-0.9% -$24.2K
SPGP icon
106
Invesco S&P 500 GARP ETF
SPGP
$2.21B
$2.71M 0.25%
23,892
ETR icon
107
Entergy
ETR
$52.6B
$2.69M 0.25%
28,887
+726
+3% +$63.9K
AZN icon
108
AstraZeneca
AZN
$258B
$2.64M 0.25%
17,225
+2,948
+21% +$446K
TMO icon
109
Thermo Fisher Scientific
TMO
$196B
$2.6M 0.24%
5,351
-4,341
-45% -$2.02M
IBM icon
110
IBM
IBM
$202B
$2.56M 0.24%
9,090
-234
-3% -$61.3K
IVW icon
111
iShares S&P 500 Growth ETF
IVW
$74.1B
$2.5M 0.23%
20,729
+42
+0.2% +$4.83K
VUG icon
112
Vanguard Growth ETF
VUG
$222B
$2.38M 0.22%
29,814
SAP icon
113
SAP
SAP
$186B
$2.38M 0.22%
8,894
+798
+10% +$224K
BRK.A icon
114
Berkshire Hathaway Class A
BRK.A
$1.06T
$2.26M 0.21%
3
USB icon
115
US Bancorp
USB
$98.6B
$2.26M 0.21%
46,779
+464
+1% +$21.9K
SONY icon
116
Sony
SONY
$124B
$2.25M 0.21%
78,241
+5,473
+8% +$147K
LAMR icon
117
Lamar Advertising Co
LAMR
$16.4B
$2.21M 0.2%
18,018
+411
+2% +$51.1K
POOL icon
118
Pool Corp
POOL
$7.27B
$2.12M 0.2%
6,824
-290
-4% -$90.9K
TSM icon
119
TSMC
TSM
$2.11T
$2.1M 0.2%
7,527
+1,443
+24% +$353K
EXG icon
120
Eaton Vance Tax-Managed Global Diversified Equity Income Fund
EXG
$2.97B
$2.1M 0.19%
230,456
ASML icon
121
ASML
ASML
$670B
$2.05M 0.19%
2,121
+368
+21% +$289K
SBUX icon
122
Starbucks
SBUX
$119B
$1.99M 0.18%
23,482
+531
+2% +$47.5K
IGA
123
Voya Global Advantage and Premium Opportunity Fund
IGA
$153M
$1.98M 0.18%
199,864
BLK icon
124
Blackrock
BLK
$165B
$1.98M 0.18%
1,695
-618
-27% -$691K
IAU icon
125
iShares Gold Trust
IAU
$62.3B
$1.97M 0.18%
27,096

Similar funds

Marks Group Wealth Management's Q3 2025 Portfolio in Review

As of Q3 2025, Marks Group Wealth Management held 307 positions worth $1.08B, up 0.11% from $1.08B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Marks Group Wealth Management's Q3 2025 filing shows 14 new, 85 increased, 125 reduced and 13 closed positions. Its largest new stake was Palantir: 38,221 shares worth $6.97M. The largest sale was Visa, an estimated $7.33M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

  • Marks Group Wealth Management's largest Q3 2025 buy was Palantir: 38,221 shares worth $6.97M.
  • Marks Group Wealth Management added most to UnitedHealth in Q3 2025, an estimated $8.51M increase.
  • Marks Group Wealth Management's biggest Q3 2025 reduction was Visa, cutting an estimated $7.33M.
  • Marks Group Wealth Management fully exited Verisk Analytics in Q3 2025, selling an estimated $3.66M.
  • Marks Group Wealth Management's ten largest holdings make up 18% of its $1.08B portfolio in Q3 2025.
  • Marks Group Wealth Management opened 14 new positions and closed 13 in Q3 2025.
  • Marks Group Wealth Management's portfolio value rose 0.11% quarter-over-quarter to $1.08B.

Based on Marks Group Wealth Management's 13F filing for Q3 2025, filed 10 Nov 2025.